# Liminatus Pharma (LIMN) — News

LIMN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/limn/news

## Recent headlines

- [Liminatus Pharma regains compliance with Nasdaq minimum bid price rule](https://www.ainvest.com/news/liminatus-pharma-regains-compliance-nasdaq-minimum-bid-price-rule-2609) — AInvest Wire, Sep 29, 2026
- [Liminatus Pharma, Inc. announces reverse stock split of its common stock](https://www.ainvest.com/news/liminatus-pharma-announces-reverse-stock-split-common-stock-2608) — AInvest Wire, Aug 18, 2026
- [Liminatus Pharma - InnocsaI merger valued at $320 mln with $0.2 per share issue price](https://www.ainvest.com/news/liminatus-pharma-innocsai-merger-valued-320-mln-0-2-share-issue-price-2607) — AInvest Wire, Jun 30, 2026
- [Liminatus Pharma - Innocsa equity holders to receive up to 19.99% of Liminatus common stock](https://www.ainvest.com/news/liminatus-pharma-innocsa-equity-holders-receive-19-99-liminatus-common-stock-2607) — AInvest Wire, Jun 30, 2026
- [Liminatus Pharma amends definitive merger agreement with InnOCSAI to expand oncology cell therapy pipeline](https://www.ainvest.com/news/liminatus-pharma-amends-definitive-merger-agreement-innocsai-expand-oncology-cell-therapy-pipeline-2607) — AInvest Wire, Jun 30, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).